GSA Capital Partners LLP Takes $685,000 Position in CorVel Corp. $CRVL

GSA Capital Partners LLP acquired a new position in CorVel Corp. (NASDAQ:CRVL) in the second quarter, Holdings Channel reports. The institutional investor acquired 10,959 shares of the business services provider’s stock, valued at approximately $685,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp increased its position in CorVel by 2.7% during the fourth quarter. State Street Corp now owns 1,179,572 shares of the business services provider’s stock valued at $79,822,000 after acquiring an additional 30,987 shares during the last quarter. Geode Capital Management LLC grew its stake in CorVel by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 927,845 shares of the business services provider’s stock worth $62,796,000 after acquiring an additional 28,666 shares in the last quarter. Norges Bank purchased a new position in CorVel during the 4th quarter worth $29,250,000. Qube Research & Technologies Ltd increased its stake in shares of CorVel by 100.9% during the third quarter. Qube Research & Technologies Ltd now owns 236,713 shares of the business services provider’s stock valued at $18,326,000 after buying an additional 118,879 shares during the period. Finally, Raymond James Financial Inc. raised its holdings in shares of CorVel by 1.3% in the 3rd quarter. Raymond James Financial Inc. now owns 221,070 shares of the business services provider’s stock valued at $17,115,000 after purchasing an additional 2,798 shares in the last quarter. Hedge funds and other institutional investors own 51.36% of the company’s stock.

Insider Activity at CorVel

In other news, VP Jennifer Yoss sold 1,999 shares of the stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $61.02, for a total value of $121,978.98. Following the sale, the vice president directly owned 2,173 shares in the company, valued at approximately $132,596.46. This trade represents a 47.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Maxim Shishin sold 2,250 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $60.59, for a total value of $136,327.50. Following the transaction, the insider directly owned 7,050 shares of the company’s stock, valued at approximately $427,159.50. This represents a 24.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 13,249 shares of company stock worth $807,126. Company insiders own 39.72% of the company’s stock.

CorVel Trading Up 5.1%

Shares of NASDAQ CRVL opened at $70.78 on Thursday. CorVel Corp. has a 12-month low of $44.83 and a 12-month high of $93.71. The stock has a market cap of $3.61 billion, a PE ratio of 31.46 and a beta of 0.98. The company has a 50-day moving average of $61.89 and a 200 day moving average of $57.55.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 EPS for the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.The firm had revenue of $259.93 million for the quarter.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Wall Street Zen raised CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Weiss Ratings upgraded shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, CorVel has a consensus rating of “Hold”.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).